Selami Çağatay ÖNAL, Hatice TURGUT, Ramazan ÖZDEMİR, İsmail Kürşad GÖKÇE, Hüseyin KAYA

The effect of defect size on mortality and morbidity in patients with neural tube defect

Aim: Neural tube defects (NTD) occur due to errors in the closing of neural canal in embryo. All over the world, the incidence of all forms of NTD varies between 1.4 and 2 in every 1000 live births. The aim of the present study was to investigate the short term prognosis, accompanying anomalies and complications in patients with NTD and to evaluate the relation between defect sizes. Material and Methods: Patients who applied to Inonu University Neonatology Department between January 2010 and December 2017 with the diagnosis of NTD and were operated on were included in the study. Babies who died within the first 24 hours were excluded from the study. Patients were divided into two groups according to the size of NTD; < 5 cm (Group 1) and ≥ 5 cm (Group 2). Approval for the study was obtained from local ethics committee. Results: Overall 133 infants were included in the study. Mean birth weight was 3155 ± 531 g and mean duration of pregnancy was on 38.1 ± 1.8 weeks. Of NTD’s 82% was located in lumbosacral region. 90.2% of the patients underwent operation within the first 24 hours. Parameters such as hydrocephalus, need for shunt, need for flap in tissue defects, the rate of postoperative complications, duration of hospitalization, mortality and the use of antibiotics were found to be at a higher rate in cases whose defect size was ≥5 cm than in those whose defect size was < 5 cm (p < 0.005). Postoperative complications developed in 48.1% of the patients. The most common complications were observed to be cerebrospinal fluid (CSF) leakage (24.1%) and bladder dysfunction (7.5%). Conclusion: In patients with NTD, as the size of the defect increases, additional interventions, complications, hospitalization rates and mortality increase as well. Therefore, it is recommended that health care personnel should take care against problems in the management of this group of patients and inform familes beforehand on these issues.

PDF

___

1. Copp AJ, Adzick NS, Chitty LS, Fletcher JM, Holmbeck GN, Shaw GM. Spina bifida. Nat Rev Dis Primers 2015;1:1-18
2. Rodrigues ABD, Krebs VLJ, Matushita H, de Carvalho WB. Shortterm prognostic factors in myelomeningocele patients. Child Nerv Syst 2017;32:675-80.
3. Bulbul A, Can E, Bulbul LG, Cömert S, Nuhoglu A. Clinical characteristics of neonatal meningomyelocele cases and effect of operation time on mortality and morbidity. Pediatr Neurosurg 2010;46:199-204.
4. Aygun C, Vurucu S, Celik FC, Dagnar A, Tanyeri B, Kucukoduk S. Experience of a tertiary care center on 100 newborns with neural tube defects. Turk J Pediatr 2013;55:359-64.
5. Haq IZ, Akmal S, Chandler CL, Bassi S. Review of practices in myelomeningocoele repair at King’s College Hospital, London. Br J Neurosurg 2012;26:851-55.
6. Attenello FJ, Tuchman A, Christian E A, Wen T, Chang KE, Nallapa S, et al. Infection rate correlated with time to repair of open neural tube defects (myelomeningoceles): an institutional and national study. Child Nerv Syst 2016;32:1675-81.
7. Beuriat PA, Poirot I, Hameury F, Szathmari A, Rousselle C, Sabatier I, et al. Postnatal Management of Myelomeningocele: Outcome with a Multidisciplinary Team Experience. World neurosurg 2018;110:24-31.
8. Tarcan T, Önol FF, ˙Ilker Y, Alpay H, ¸Sim¸sek F, Özek M. The timing of primary neurosurgical repair significantly affects neurogenic bladder prognosis in children with myelomeningocele. J Urol 2006;176:1161-65.
9. Blount JP, George TM, Koueik J, Iskandar BJ. Concepts in the neurosurgical care of patients with spinal neural tube defects: An embryologic approach. Birth Defects Res 2019;111:1564-76.
10. Schroeder HK, Nunes JC, Madeira L, Moritz JLW, Walz R, Linhares MN. Postsurgical infection after myelomeningocele repair: A multivariate analysis of 60 consecutive cases. Clin Neurol Neurosurg 2012;114:981-85.
11. Gurbuz MS, Yuksel MO. The association between the timing of shunt placement and shunt infection in hydrocephalus associated with myelomeningocele. Turk Neurosurg 2020;30:94-8.
12. Oncel MY, Ozdemir R, Kahilogulları G, Yurttutan S, Erdeve O, Dilmen U. The effect of surgery time on prognosis in newborns with meningomyelocele. J Korean Neurosurg Soc 2012;51:359-62.
13. Januschek E, Röhrig A, Kunze S, Fremerey C, Wiebe B, Messing-Jünger M Myelomeningocele - a single institute analysis of the years 2007 to 2015. Child Nerv Syst 2016;32:1281-87.
14. ˙Ilhan Ö, Özdemir SA, Özdemir N, Akbay S, Kanar B, Memur ¸S, et al. Prognostic factors And accompanying anomalies in neonates with meningomyelocele: Experience of 40 patients. Gynecology-Obstetrics and Neonatology Medical Journal 2017;14:163-67.
15. Danzer E, Finkel R, Gerdes M, Schwartz EMS, Rintoul NN, Adzick NS, et al. The relationship of seizure activity and chronic epilepsy in early infancy and short-term neurodevelopmental outcome following fetal myelomeningocele closure. Neuropediatrics 2012;41:140-43.
16. Rehman L, Shiekh M, Afzal A, Rizvi R. Risk factors, presentation and outcome of meningomyelocele repair. Pak J Med Sci 2020;36:422.
17. Gunay H, Sozbilen MC, Gurbuz Y, Altinisik M, Buyukata B. Incidence and type of foot deformities in patients with spina bifida according to level of lesion. Child Nerv Syst 2016;32:315-19.
18. Salomão RM, Cervante TP, Salomão JFM, Leon SVA. The mortality rate after hospital discharge in patients with myelomeningocele decreased after implementation of mandatory flour fortification with folic acid. Arq Neuropsiquiatr 2017;75:20-4.